logo

PBH

Prestige Consumer Healthcare·NYSE
--
--(--)
--
--(--)
7.03 / 10
Outperform

Fundamental analysis rates the stock as Outperform with a 7.0/10 score. Key strengths include favorable Asset-MV (-0.5007) and Cash-MV (0.4791) ratios, indicating solid asset backing and cash flow. However, Basic EPS and Diluted EPS YoY growth rates (2.6128 and 2.8777) are modest, capping upside. Net income exceeded revenue, placing Net income-Revenue in performance group 4. Overall, the company's fundamentals are solid but not exceptional, warranting cautious optimism.

Fundamental(7.03)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-0.26
Score0/3
Weight-9.92%
1M Return-2.93%
Net cash flow from operating activities per share (YoY growth rate %)
Value1.68
Score2/3
Weight5.62%
1M Return1.41%
Net income-Revenue
Value0.28
Score3/3
Weight30.64%
1M Return6.40%
Basic earnings per share (YoY growth rate %)
Value2.61
Score1/3
Weight2.41%
1M Return0.58%
Total profit (YoY growth rate %)
Value2.96
Score1/3
Weight6.43%
1M Return1.57%
Net cash flow from operating activities (YoY growth rate %)
Value1.04
Score1/3
Weight2.29%
1M Return0.62%
Diluted earnings per share (YoY growth rate %)
Value2.88
Score1/3
Weight2.23%
1M Return0.52%
Asset-MV
Value-0.50
Score3/3
Weight18.27%
1M Return4.29%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value2.52
Score1/3
Weight8.87%
1M Return2.16%
Cash-MV
Value0.48
Score3/3
Weight33.16%
1M Return7.22%
Is PBH fundamentally strong?
  • PBH scores 7.03/10 on fundamentals and holds a Discounted valuation at present. Backed by its 7.44% ROE, 16.90% net margin, 16.83 P/E ratio, 1.72 P/B ratio, and -11.60% earnings growth, these metrics solidify its Outperform investment rating.